Literature DB >> 2670747

Very early (VEA) and very late (VLA) activation antigens have distinct functions in T lymphocyte activation.

W M Yokoyama1, S R Maxfield, E M Shevach.   

Abstract

We have described in detail the properties of two types of murine T-cell activation antigen. mAbs to these cell surface antigens were initially identified because they demonstrated apparent selective reactivity with a number of cloned cell lines derived from dendritic epidermal T cells. After careful study, both of these antigens were also found to be expressed by normal T cells. The dimer recognized by mAb H1.2F3 which we have termed Very Early Activation (VEA) antigen, is rapidly and transiently expressed during the process of normal T-cell activation. It is likely that the VEA antigen plays a major role in T-cell activation as mAb H1.2F3 is a potent stimulator of T-cell proliferation in the presence of PMA and accessory cells. The second cell surface antigen recognized by mAbs H9.2B8 and 8.18E12 is a Very Late Activation (VLA) antigen that has biochemical, tissue distribution, and functional properties which resemble the human VLA antigens, which have been recently shown to be members of the integrin superfamily of cell surface receptors. While the physiologic ligand for the VEA antigen has yet to be identified, the integrin identified by mAbs H9.2B8 and 8.18E12 mediates cell adhesion to a well-defined group of ligands consisting of the ECM-proteins fibronectin, fibrinogen, and vitronectin. We postulate that the VEA and VLA antigens have distinctly different functions and that further detailed analysis of these dimers will further elucidate the role of these cell surface antigens in T-cell activation and function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670747     DOI: 10.1111/j.1600-065x.1989.tb00024.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  13 in total

1.  A family of beta 7 integrins on human mucosal lymphocytes.

Authors:  C M Parker; K L Cepek; G J Russell; S K Shaw; D N Posnett; R Schwarting; M B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

2.  Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.

Authors:  C Cambiaggi; M T Scupoli; T Cestari; F Gerosa; G Carra; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  α2β1 Integrin Is Required for Optimal NK Cell Proliferation during Viral Infection but Not for Acquisition of Effector Functions or NK Cell-Mediated Virus Control.

Authors:  Colby Stotesbury; Pedro Alves-Peixoto; Brian Montoya; Maria Ferez; Savita Nair; Christopher M Snyder; Shunchuan Zhang; Cory J Knudson; Luis J Sigal
Journal:  J Immunol       Date:  2020-02-03       Impact factor: 5.422

4.  Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue.

Authors:  E D Silverman; B Isacovics; D Petsche; R M Laxer
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

5.  Melanoma cells treated with GGTI and IFN-gamma allow murine vaccination and enhance cytotoxic response against human melanoma cells.

Authors:  Guillaume Sarrabayrouse; Christine Pich; Raphaël Moriez; Virginie Armand-Labit; Philippe Rochaix; Gilles Favre; Anne-Françoise Tilkin-Mariamé
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

6.  Accumulation of plasma cells in inflamed sites: effects of antigen, nonspecific microbial activators, and chronic inflammation.

Authors:  S M Mallison; J P Smith; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Human HLA-DR transgenes protect mice from fatal virus-induced encephalomyelitis and chronic demyelination.

Authors:  Moses Rodriguez; Laurie Zoecklein; Jason G Kerkvliet; Kevin D Pavelko; Louisa Papke; Charles L Howe; Larry R Pease; Chella David
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

8.  Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning.

Authors:  M F Lopes; G A dos Reis
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

9.  Trypanosoma cruzi-induced immunosuppression: selective triggering of CD4+ T-cell death by the T-cell receptor-CD3 pathway and not by the CD69 or Ly-6 activation pathway.

Authors:  M F Lopes; G A DosReis
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

10.  Virus-induced maturation and activation of autoreactive memory B cells.

Authors:  A J Reed; M P Riley; A J Caton
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.